To make things easier, leave this box checked On shared devices, we recommend that you disconnect from Euroquity when you are done
Email

You will receive an email to define a new password

Location

Select your country

and your language

Hi ,

Welcome to your personnel profile page! Fill in your information in order to become more visible to organizations that interest you.

% completed

%

medal 2
This profile is validated by 2 label.

Company

Prometheus Srl

Prometheus Srl_logo
30
EQ SCORE

The EQ Score shows the company's activity and appeal on the platform: profile completeness, news, likes, follows, membership in one or more labels or communities, number of members in its network, etc.

Prometheus develops medical devices for regenerative medicine. The first product is Ematik: a patch for wound care combining patient's blood with biomaterials. The product is already on the vet market and it will be certified for human applications

Mirandola, Emilia-Romagna, Italy

Send a message

English

Prometheus Srl

English

Prometheus is an Italian innovative Startup working in the field of Medical devices with application on regenerative medicine.

The company, incorporated in November 2017, is based in Mirandola (MO), Italy, one of the most important European Districts for Medical Devices. The team is now composed by 3 co-founders with a background on biotechnologies, 3D printing and device automation

See more

Prometheus is an Italian innovative Startup working in the field of Medical devices with application on regenerative medicine.

The company, incorporated in November 2017, is based in Mirandola (MO), Italy, one of the most important European Districts for Medical Devices. The team is now composed by 3 co-founders with a background on biotechnologies, 3D printing and device automation and an employee working as Marketing & Communication Responsible.

The Team is supported by an official Advisory Board including representatives from the Financial, Scientific and Helathcare Regulatory fields. In particular, Dr. Andrea Chiesi (R&D portfolio manager of Chiesi Farmaceutici S.p.A., one of the most important European pharma companies) is one of the older members of our advisory board, supporting the team in the definition of regulatory steps, related budget and in the establishment of networks.

Prometheus also collaborates with universities, such as the University of Parma and Perugia, that are supporting and validating the project under a scientific, technical and clinical point of view.

The Ematik project for human wound care has been also validated and is now supported by important and well re-known Clinical key opinion leaders, working both in the field of chronic wounds and surgical wounds.

  • 1

    Followers

Team member(s)

Your request has been sent
Join this organization
Your request has been sent

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

InvestHorizon - Accelerated
The InvestHorizon Accelerated label is for selected deep tech companies from the accelerator programme to facilitate series A funding.  This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential. InvestHorizon is a programme financed by the European Commission in association with Eureka to foster investment readiness.
454 Entities
Seal of Excellence
The Seal of Excellence is a quality label awarded to project proposals submitted to Horizon 2020 which succeeded a highly competitive evaluation process by independent experts, but did not receive funding due to budget limits. This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.
1482 Entities

Communities

InvestHorizon
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding for selected DEEP TECH companies.
2672 Members
Access2EIC
The Access2EIC -Seal of Excellence community aims at gathering high potential European companies that received from the European Commission a “Seal of Excellence” certificate and European equity investors. https://access2eic.eu/
2141 Members